Bumetanide — 0.25MG/ML, Injection, carton of 10 × 4 mL vials

Bumetanide — 0.25MG/ML, Injection, carton of 10 × 4 mL vials

Bumetanide is a injection for intramuscular; intravenous use. Bumetanide Injection is indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide.

• Active ingredient or product type: BUMETANIDE
• Strength/concentration: 0.25MG/ML
• Dosage form and route: Injection, Intramuscular; Intravenous
• Exact package presentation: carton of 10 × 4 mL vials
• NDC/item number: 0641-6008-10
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at controlled room temperature according to the current product labeling.
• Status: Rx only

Important safety information: Review the current product labeling for product-specific contraindications, warnings, and precautions before use.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.